Article
Retention of the p53 codon 72 arginine allele is associated with a reduction of disease-free and overall survival in arginine/proline heterozygous breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Oct 2003
Bonafé Massimiliano, Ceccarelli Claudio, Farabegoli Fulvia, Santini Donatella, Taffurelli Mario, Barbi Cristiana, Marzi Erika, Trapassi Chiara, Storci Gianluca, Olivieri Fabiola, Franceschi Claudio
Abstract excerpt
PURPOSE: The arginine to proline substitution at codon 72 represents a common aminoacidic polymorphism of the p53 protein. Recent data suggest that p53 codon 72 may modulate the response to cancer therapy. The aim of this study was to test the hypothesis that the p53 codon 72 genotype, evaluated in the tumor tissue and in the disease-free lymph node, is related to differences in disease-free and overall survival...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
